Table 3.
Univariable and multivariable cox regression analysis for overall survival (OS) in all patients.
| Characteristics | Univariable analysis | Multivariable analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95%Cl | P | HR | 95%Cl | P | |
| Gender | 0.322 | |||||
| Male | reference | |||||
| Female | 0.767 | 0.454-1.297 | ||||
| Age(y) | 0.122 | 0.130 | ||||
| <65 | reference | reference | ||||
| ≥65 | 1.524 | 0.894-2.600 | 1.519 | 0.885-2.610 | ||
| Smoking History | 0.734 | |||||
| Yes | reference | |||||
| No | 0.915 | 0.548-1.528 | ||||
| TNM stage | 0.400 | |||||
| III | reference | |||||
| IV | 1.441 | 0.616-3.372 | ||||
| Histology | 0.368 | |||||
| Squamous | reference | |||||
| Adenocarcinoma | 0.377 | 0.195-1.665 | ||||
| ECOG-PS | 0.006 | 0.008 | ||||
| 0-1 | reference | reference | ||||
| 2 | 2.210 | 1.191-3.841 | 2.270 | 1.112-3.877 | ||
| EGFR mutation type | 0.531 | |||||
| 19del | reference | |||||
| 21L858R | 0.789 | 0.452-1.379 | 0.406 | |||
| Otders | 1.231 | 0.502-3.015 | 0.650 | |||
| Primary brain metastasis | 0.745 | |||||
| Yes | reference | |||||
| No | 0.912 | 0.522-1.592 | ||||
| Primary liver metastasis | 0.032 | 0.037 | ||||
| Yes | reference | reference | ||||
| No | 0.457 | 0.194-0.772 | 0.550 | 0.230-0.793 | ||
| Post-line immunotderapy | 0.012 | 0.005 | ||||
| Yes | reference | reference | ||||
| No | 1.963 | 1.163-3.314 | 2.184 | 1.273-3.746 | ||
ECOG-PS, Eastern cooperative oncology group-performance status; EGFR, epidermal growth factor receptor.
The bold values mean these characters are both significant in univariable and multivarible analysis.